source
- Administrative gap stalls access to new pancreatic cancer therapyA recent Morning Rounds report notes that patients awaiting a new pancreatic cancer treatment are encountering delays because an administrative gap has halted its rollout. The story explains that…
- Menarini to launch Gan & Lee’s GLP-1 drug bofanglutide across Europe in $771 M partnershipItalian firm Menarini Group has entered a licensing agreement with Chinese insulin producer Gan & Lee Pharmaceuticals to bring the GLP-1 compound bofanglutide to Europe. The deal includes an upfro…